流化床法制备的非诺贝特固体分散体小丸: 物理表征、改善溶出和犬口服生物利用度

流化床法制备的非诺贝特固体分散体小丸: 物理表征、改善溶出和犬口服生物利用度

唐宁, 赖捷, 陈雅聘, 卢懿^*, 吴伟^*

复旦大学药学院药剂学教研室, 上海 201203

收稿日期:2009-03-11 修回日期:2009-05-10 出版日期:2009-06-15 发布日期:2009-06-15
通讯作者: 卢懿*, 吴伟*

Fenofibrate solid dispersion pellets prepared by fluid-bed coating: physical characterization, improved dissolution and oral bioavailability in beagle dogs

Ning Tang, Jie Lai, Ya-Pin Chen, Yi Lu^*, Wei Wu^*

Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China

Received:2009-03-11 Revised:2009-05-10 Online:2009-06-15 Published:2009-06-15
Contact: Yi Lu*, Wei Wu*

摘要/Abstract

摘要： 采用流化床包衣法制备难溶性药物非诺贝特(FNB)-PEG6000的固体分散体。差示扫描量热法和X-射线粉末衍射法对固体分散体中非诺贝特的物相进行鉴别, 结果表明非诺贝特在固体分散体中以微晶形式存在。在含1%十二硫酸钠的水、FASSIF和FESSIF中对其溶出行为进行了考察, 结果表明在PEG/FNB的比例为4/1以上, 非诺贝特的体外溶出显著提高, 30分钟溶出接近完全。然而, 在较小PEG/FNB比例时, 溶出并未显著提高。经测定血浆中非诺贝酸的含量, 对非诺贝特固体分散体小丸的口服生物利用度进行了研究。PEG/FNB比例为3/1和4/1的固体分散体小丸其口服生物利用度相对于微粉化的非诺贝特lipanthyl提高了近3.4和4.4倍, 口服生物利用度显著依赖于体外溶出速率。体内外相关性研究表明非诺贝特吸收分数与含1%十二硫酸钠的水、FASSIF和FESSIF中的溶出速率有很好的相关性。非诺贝特-PEG6000固体分散体小丸可用于提高其溶出速率和生物利用度, 并具有良好体内外相关性。

关键词: 固体分散体, 小丸, 流化床, 包衣, 非诺贝特, 体内外相关

Abstract:

Solid dispersion of fenofibrate (FNB), a poorly water-soluble drug, was prepared by a fluid-bed coating technique with PEG 6000 as the carrier. The physical state was characterized by DSC and X-ray powder diffractometry, which indicated the existence of fenofibrate in crystalline form in the solid dispersion. In vitro dissolution was studied in water containing 1% sodium lauryl sulfate, FASSIF and FESSIF. Significant enhancement in dissolution was achieved at PEG/FNB ratio of 4/1 with near complete dissolution within 30 min. Moderate improvement in dissolution rate was observed at smaller PEG/FNB ratios. Oral bioavailability was studied in beagle dogs after oral administration of fenofibrate solid dispersion pellets by monitoring fenofibric acid in plasma. The oral bioavailability of PEG/FNB 3/1 and 4/1 solid dispersion pellets was improved by 3.4 and 4.4-fold as compared to Lipanthyl^®, a commercial micronized fenofibrate formulation. There was a strong dependence of oral bioavailability on the in vitro dissolution rate. Good correlation was observed between the in vivo absorption fraction and the in vitro dissolution rate in each of the dissolution media, water containing 1% sodium lauryl sulfate, FASSIF and FESSIF. It could be concluded that PEG/FNB solid dispersion pellets were able to improve the dissolution and oral bioavailability of fenofibrate.

Key words: Solid dispersion, Solid dispersion, Pellets, Pellets, Fluid-bed, Fluid-bed, Coating, Coating, Fenofibrate, Fenofibrate, Bioavailability, Bioavailability

中图分类号:

945.1

Supporting:

Foundation item: Shanghai Municipal Committee of Science and Technology (Grant No. 0852nm04400).

^*Correspondence author. Tel.: 86-21-51980002;

e-mail: wuwei@shmu.edu.cn

唐宁, 赖捷, 陈雅聘, 卢懿^*, 吴伟^*. 流化床法制备的非诺贝特固体分散体小丸: 物理表征、改善溶出和犬口服生物利用度[J]. .

Ning Tang, Jie Lai, Ya-Pin Chen, Yi Lu^*, Wei Wu^*. Fenofibrate solid dispersion pellets prepared by fluid-bed coating: physical characterization, improved dissolution and oral bioavailability in beagle dogs[J]. .

[1]	高美琪, 吴佳丽, 朱文静, 张晓彤, 樊文玲. 利用热熔挤出技术制备和表征白藜芦醇缓释固体分散体[J]. 中国药学(英文版), 2023, 32(3): 165-179.
[2]	樊文玲, 徐艳, 张心怡, 狄留庆, 李磊. 三元固体分散体提高利多卡因溶解度研究[J]. 中国药学(英文版), 2020, 29(1): 55-65.
[3]	尹雅杰, 张小飞, 崔征, 曲伟, 何冰, 代文兵, 张华, 王学清, 张强. 热熔挤出法制备的非诺贝特纳米骨架系统的体外释放和口服生物利用度研究[J]. 中国药学(英文版), 2019, 28(5): 329-338.
[4]	刘蒸生, 郝海军, 范明松. 槲皮素磷脂复合物固体分散体和固体分散体的制备及评价[J]. 中国药学(英文版), 2019, 28(12): 868-877.
[5]	程士轩, 马迎聪, 刘瑜洁, 庞宁, 李骥, 沙勐, 任汝通, Nuramatjan Ablat, 曹静, 孙懿, 蒲小平, 叶敏, 齐宪荣. 红花抗帕金森病有效成分滴丸的制备和表征[J]. 中国药学(英文版), 2019, 28(1): 27-39.
[6]	吴先闯, 王姣姣, 郝海军, 宋晓勇, 张永州, 刘瑜新, 张红芹. 高乌甲素固体分散体单层渗透泵和高乌甲素双层渗透泵的制备及体外释药行为研究[J]. 中国药学(英文版), 2017, 26(6): 413-422.
[7]	郝海军, 贾幼智, 张红芹, 韩茹, 王雪萍, 韩丽妹, 王建新. 槲皮素固体分散体单层渗透泵片的研制[J]. 中国药学(英文版), 2015, 24(6): 383-392.
[8]	吴先闯, 郝海军, 刘瑜新, 宋晓勇, 张永州, 张红芹. 羟基喜树碱磷脂复合物固体分散体和油制剂生物利用度的比较[J]. 中国药学(英文版), 2015, 24(12): 780-788.
[9]	马维娜, 谷福根, 王毅, 孟根达来, 吴春芝. 羟丙基-β-环糊精对水难溶性药物利培酮的包合及促溶作用[J]. 中国药学(英文版), 2015, 24(1): 47-53.
[10]	宋文丁, 杜若, 宋平, 钟婷, 张卫强, 赵阳, 王超, 张烜, 张强. 非布索坦二氧化硅固体分散体的制备及表征[J]. 中国药学(英文版), 2014, 23(7): 463-470.
[11]	马燕^*, 李卫中, 古锦辉. 难溶性药物水飞蓟宾固体分散体的制备及评价[J]. , 2011, 20(6): 604-608.
[12]	张志宏, 王昶光, 孙光美, 李宁, 彭博, 潘卫三^* . 两种双嘧达莫缓控释制剂比格犬体内药动学考察 [J]. , 2008, 17(4): 297-302.
[13]	孙葭北, 刘祥瑞, 王坚成, 吕万良, 张烜*, 张强. 紫杉醇-PVP固体分散体的制备、物相鉴定及细胞药效 [J]. , 2008, 17(2): 113-117.
[14]	刘祥瑞, 吴科春, 张春晖, 张烜^*, 张强 . 反相高效液相色谱法测定紫杉醇固体分散体中紫杉醇的含量[J]. , 2007, 16(2): 101-104.
[15]	朱静, 杨照罡, 陈晓梅, 孙葭北, 古丽斯坦·阿吾提, 张烜^*, 张强. 槲皮素PVP固体分散体的制备及物相鉴定[J]. , 2007, 16(1): 51-56.